US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

The reasons for the shortages vary depending on who makes the generic medication. For example, Alvogen and Sun Pharma cite “regulatory delays” for their shortages. But Amneal, Hikma ...

Hikma Pharmaceuticals will acquire parts of Danish firm Xellia Pharmaceuticals, a drug company specialising in injectable ...

Hikma Pharmaceuticals Usa Inc was founded in ... substances that are used for their pharmacological properties to make medications, including antibiotics, basic vitamins, salicylic acids and ...

2 Non-stimulant ADHD medications of different classifications work in different ways. Both Alpha-2 adrenergic agonists and SNRIs affect norepinephrine (or noradrenaline) levels in the nervous ...

If lifestyle changes alone don’t allow you to meet your blood sugar and A1C goals, your doctor may prescribe medication. Here are some factors you and your doctor may consider when deciding ...

"I wish I had known that to begin with," she says. "I would have stuck with water." The Food and Drug Administration (FDA) estimates that as many as half the people taking medications at any given ...

One of the most prominent medical developments in recent years has been the emergence of a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The best known of these ...

General Anesthesia Drugs MarketThe global general anesthesia drugs market, valued at USD 4,978.1 million in 2023, is poised for steady growth, with projections indicating a compound annual growth rate ...

Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 ...